Predictive Risk Factors for Childbirth-Associated Breast Infections in the United States: A 10-Year Perspective
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Pevzner, M.; Dahan, A. Mastitis While Breastfeeding: Prevention, the Importance of Proper Treatment, and Potential Complications. J. Clin. Med. 2020, 9, 2328. [Google Scholar] [CrossRef]
- Westerfield, K.L.; Koenig, K.; Oh, R. Breastfeeding: Common Questions and Answers. Am. Fam. Physician 2018, 98, 368–373. [Google Scholar] [PubMed]
- Victora, C.G.; Bahl, R.; Barros, A.J.D.; Franca, G.V.A.; Horton, S.; Krasevec, J.; Murch, S.; Sankar, M.J.; Walker, N.; Rollins, N.C.; et al. Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet 2016, 387, 475–490. [Google Scholar] [CrossRef] [PubMed]
- Angelopoulou, A.; Field, D.; Ryan, C.A.; Stanton, C.; Hill, C.; Ross, R.P. The microbiology and treatment of human mastitis. Med. Microbiol. Immunol. 2018, 207, 83–94. [Google Scholar] [CrossRef]
- Boakes, E.; Woods, A.; Johnson, N.; Kadoglou, N. Breast Infection: A Review of Diagnosis and Management Practices. Eur. J. Breast Health 2018, 14, 136–143. [Google Scholar] [CrossRef]
- Kataria, K.; Srivastava, A.; Dhar, A. Management of Lactational Mastitis and Breast Abscesses: Review of Current Knowledge and Practice. Indian J. Surg. 2012, 75, 430–435. [Google Scholar] [CrossRef]
- Amir, L.H.; A Forster, D.; Lumley, J.; McLachlan, H. A descriptive study of mastitis in Australian breastfeeding women: Incidence and determinants. BMC Public Health 2007, 7, 62. [Google Scholar] [CrossRef]
- Mitchell, K.B.; Johnson, H.M.; Rodríguez, J.M.; Eglash, A.; Scherzinger, C.; Widmer, K.; Berens, P.; Miller, B.; The Academy of Breastfeeding Medicine. Academy of Breastfeeding Medicine Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. Breastfeed. Med. 2022, 17, 360–376. [Google Scholar]
- Rimoldi, S.G.; Pileri, P.; Mazzocco, M.I.; Romeri, F.; Bestetti, G.; Calvagna, N.; Tonielli, C.; Fiori, L.; Gigantiello, A.; Pagani, C.; et al. The Role of Staphylococcus aureus in Mastitis. J. Hum. Lact. 2019, 36, 503–509. [Google Scholar] [CrossRef]
- Jahanfar, S.; Ng, C.J.; Teng, C.L. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst. Rev. 2013, CD005458. [Google Scholar] [CrossRef]
- Kinlay, J.R.; O’Connell, D.L.; Kinlay, S. Incidence of mastitis in breastfeeding women during the six months after delivery: A prospective cohort study. Med. J. Aust. 1998, 169, 310–312. [Google Scholar] [CrossRef] [PubMed]
- David, M.; Handa, P.; Castaldi, M. Predictors of outcomes in managing breast abscesses-A large retrospective single-center analysis. Breast J. 2018, 24, 755–763. [Google Scholar] [CrossRef]
- Irusen, H.; Rohwer, A.C.; Steyn, D.W.; Young, T. Treatments for breast abscesses in breastfeeding women. Cochrane Database Syst. Rev. 2015, 2015, CD010490. [Google Scholar] [CrossRef]
- Pustotina, O. Management of mastitis and breast engorgement in breastfeeding women. J. Matern. Neonatal Med. 2015, 29, 3121–3125. [Google Scholar] [CrossRef] [PubMed]
- HCUP NIS Description of Data Elements. Healthcare Cost and Utilization Project (HCUP). September 2008. Agency for Healthcare Research and Quality, R., MD. Available online: www.hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp (accessed on 31 March 2021).
- Mathews, T.J. NCHS Data Brief, No 232; National Center for Health Statistics: Hyattsville, MD, USA, 2016. [Google Scholar]
- Foxman, B.; D’Arcy, H.; Gillespie, B.; Bobo, J.K.; Schwartz, K. Lactation Mastitis: Occurrence and Medical Management among 946 Breastfeeding Women in the United States. Am. J. Epidemiol. 2002, 155, 103–114. [Google Scholar] [CrossRef] [PubMed]
- Kaufmann, R.; Foxman, B. Mastitis among lactating women: Occurrence and risk factors. Soc. Sci. Med. 1991, 33, 701–705. [Google Scholar] [CrossRef] [PubMed]
- Kvist, L.J.; Rydhstroem, H. Factors related to breast abscess after delivery: A population-based study. BJOG Int. J. Obstet. Gynaecol. 2005, 112, 1070–1074. [Google Scholar] [CrossRef]
- Wilson, E.; Woodd, S.L.; Benova, L. Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review. J. Hum. Lact. 2020, 36, 673–686. [Google Scholar] [CrossRef] [PubMed]
- Cullinane, M.; Amir, L.H.; Donath, S.M.; Garland, S.M.; Tabrizi, S.N.; Payne, M.S.; Bennett, C.M. Determinants of mastitis in women in the CASTLE study: A cohort study. BMC Fam. Pract. 2015, 16, 181. [Google Scholar] [CrossRef]
- Deng, Y.; Huang, Y.; Ning, P.; Ma, S.-G.; He, P.-Y.; Wang, Y. Maternal Risk Factors for Lactation Mastitis: A Meta-analysis. West. J. Nurs. Res. 2020, 43, 698–708. [Google Scholar] [CrossRef]
- Mediano, P.; Fernández, L.; Rodríguez, J.M.; Marín, M. Case–control study of risk factors for infectious mastitis in Spanish breastfeeding women. BMC Pregnancy Childbirth 2014, 14, 195. [Google Scholar] [CrossRef]
- Rowe-Murray, H.J.; Fisher, J.R. Baby friendly hospital practices: Cesarean section is a persistent barrier to early initiation of breastfeeding. Birth 2002, 29, 124–131. [Google Scholar] [CrossRef] [PubMed]
- Hall, M.J.; Owings, M. Rural and urban hospitals’ role in providing inpatient care, 2010. NCHS Data Brief 2014, 147, 1–8. [Google Scholar]
- Ryan, G.B.; Majno, G. Acute inflammation. A review. Am. J. Pathol. 1977, 86, 183–276. [Google Scholar] [PubMed]
- BuBuster, K.J.; Stevens, E.I.; Elmets, C.A. Dermatologic Health Disparities. Dermatol. Clin. 2012, 30, 53–59. [Google Scholar] [CrossRef] [PubMed]
- Hereford, B.; Kim, Y.; Zaenglein, A.L.; Hollins, L.C. Photographic representation of skin tones in three dermatology journals. Pediatr. Dermatol. 2021, 38, 146–148. [Google Scholar] [CrossRef]
- McMichael, A.J.; Jackson, S. Issues In Dermatologic Health Care Delivery In Minority Populations. Dermatol. Clin. 2000, 18, 229–233. [Google Scholar] [CrossRef]
- Wilson, B.N.; Sun, M.; Ashbaugh, A.G.; Ohri, S.; Yeh, C.; Murrell, D.F.; Murase, J.E. Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action. Int. J. Women Dermatol. 2021, 7, 391–397. [Google Scholar] [CrossRef]
- Bharat, A.; Gao, F.; Aft, R.L.; Gillanders, W.E.; Eberlein, T.J.; Margenthaler, J.A. Predictors of Primary Breast Abscesses and Recurrence. World J. Surg. 2009, 33, 2582–2586. [Google Scholar] [CrossRef]
- Rizzo, M.; Gabram, S.; Staley, C.; Peng, L.; Frisch, A.; Jurado, M.; Umpierrez, G. Management of breast abscesses in nonlactating women. Am. Surg. 2010, 76, 292–295. [Google Scholar] [CrossRef]
The Current Study Population, N (%) | All Other Deliveries, N (%) | p | ||
---|---|---|---|---|
All Cases | 4614 | 9,116,723 | ||
Race | White | 2157 (55.05%) | 3,953,401 (51.7%) | 0.003 |
Black | 535 (13.65%) | 1,120,382 (14.6%) | ||
Hispanic | 856 (21.85%) | 1,760,773 (23%) | ||
Asian/Pacific Islander | 159 (4.05%) | 380,928 (5%) | ||
Native American | 30 (0.8%) | 64,059 (0.8%) | ||
Other | 34 (4.6%) | 370,205 (4.8%) | ||
Income Quartile | Quartile 1 | 1279 (28%) | 2,501,886 (28%) | 0.007 |
Quartile 2 | 1064 (23.4%) | 2,271,203 (25.4%) | ||
Quartile 3 | 1145 (25.25%) | 2,192,311 (24.5%) | ||
Quartile 4 | 1067 (23.35%) | 1,980,779 (22.1%) | ||
Insurance | Private Insurance | 2309 (50%) | 4,480,575 (49.2%) | 0.001 |
Medicare | 27 (0.6%) | 68,482 (0.8%) | ||
Medicaid | 1931 (42%) | 3,968,701 (43.6%) | ||
Self-Pay | 186 (4%) | 315,717 (3.5%) | ||
No Charge | 19 (0.4%) | 19,080 (0.2%) | ||
Other | 138 (3%) | 254,963 (2.8%) | ||
Continuous Variables | Mean (SD) | Mean (SD) | p | |
Age, Years | 26.75 (6) | 27.7 (6.1) | 0.0001 | |
Time to First Procedure, Days | 0.93 (1.25) | 0.47 (2.08) | 0.0001 | |
Length of Stay, Days | 2.83 (1.9) | 2.67 (2.64) | 0.0001 | |
Total Charges, Dollars | 13,407 (12,783) | 13,115 (15,065) | 0.5 |
Abscess, N (%) | Nipple Infection, N (%) | Mastitis, N (%) | p | ||
---|---|---|---|---|---|
All Cases | 1876 (40.7%) | 35 (0.8%) | 2703 (58.6%) | ||
Age Group | 12–17 years | 114 (6.1%) | 1 (2.9%) | 97 (3.6%) | <0.001 |
18–21 years | 350 (18.7%) | 7 (20.0%) | 423 (15.7%) | ||
22–30 years | 942 (50.4%) | 15 (42.9%) | 1342 (49.7%) | ||
31+ years | 464 (24.8%) | 12 (34.3%) | 838 (31.0%) | ||
Race | White | 733 (45.4%) | 19 (57.6%) | 1405 (61.9%) | <0.001 |
Black | 325 (20.1%) | 7 (21.2%) | 203 (8.9%) | ||
Hispanic | 393 (24.3%) | 4 (12.1%) | 459 (20.2%) | ||
Asian/Pacific Islander | 68 (4.2%) | 1 (3.0%) | 90 (4.0%) | ||
Native American | 14 (0.9%) | 0 (0%) | 16 (0.7%) | ||
Other | 81 (5.0%) | 2 (6.1%) | 98 (4.3%) | ||
Income Quartile | Quartile 1 | 620 (33.6%) | 11 (31.4%) | 648 (24.2%) | <0.001 |
Quartile 2 | 439 (23.8%) | 11 (31.4%) | 614 (22.9%) | ||
Quartile 3 | 422 (22.9%) | 5 (14.3%) | 718 (26.8%) | ||
Quartile 4 | 363 (19.7%) | 8 (22.9%) | 696 (26.0%) | ||
Insurance | Private Insurance | 749 (40.0%) | 13 (37.1%) | 1547 (57.3%) | <0.001 |
Medicare | 14 (0.7%) | 0 (0%) | 13 (0.5%) | ||
Medicaid | 958 (51.1%) | 19 (54.3%) | 954 (35.3%) | ||
Self-Pay | 95 (5.1%) | 2 (5.7%) | 89 (3.3%) | ||
No Charge | 12 (0.6%) | 1 (2.9%) | 6 (0.2%) | ||
Other | 46 (2.5%) | 0 (0%) | 92 (3.4%) | ||
Severity | Minor Loss of Function | 278 (14.8%) | 25 (71.4%) | 1716 (63.5%) | <0.001 |
Moderate Loss of Function | 1524 (81.2%) | 7 (20.0%) | 789 (29.2%) | ||
Major Loss of Function | 67 (3.6%) | 3 (8.6%) | 186 (6.9%) | ||
Extreme Loss of Function | 7 (0.4%) | 0 (0%) | 12 (0.4%) | ||
Comorbidities | AIDS | 2 (0.1%) | 0 (0%) | 0 (0%) | 0.230 |
Alcohol Abuse | 4 (0.2%) | 0 (0%) | 0 (0%) | 0.054 | |
Deficiency Anemias | 149 (7.9%) | 3 (8.6%) | 170 (6.3%) | 0.090 | |
Rheumatoid Arthritis | 8 (0.4%) | 0 (0%) | 10 (0.4%) | 0.890 | |
Chronic Blood Loss | 132 (7.0%) | 3 (8.6%) | 169 (6.3%) | 0.510 | |
Congestive Heart Failure | 0 (0%) | 0 (0%) | 1 (0.0%) | 0.700 | |
Chronic Pulmonary Disease | 81 (4.3%) | 1 (2.9%) | 106 (3.9%) | 0.750 | |
Coagulopathy | 8 (0.4%) | 1 (2.9%) | 15 (0.6%) | 0.130 | |
Depression | 53 (2.8%) | 0 (0%) | 70 (2.6%) | 0.550 | |
Diabetes, Uncomplicated | 34 (1.8%) | 0 (0%) | 27 (1.0%) | 0.048 | |
Diabetes, Chronic Complications | 9 (0.5%) | 0 (0%) | 1 (0.0%) | 0.006 | |
Drug Abuse | 29 (1.5%) | 1 (2.9%) | 6 (0.2%) | <0.001 | |
Hypertension | 54 (2.9%) | 0 (0%) | 41 (1.5%) | 0.004 | |
Hypothyroidism | 29 (1.5%) | 0 (0%) | 62 (2.3%) | 0.140 | |
Liver Disease | 4 (0.2%) | 0 (0%) | 4 (0.1%) | 0.850 | |
Lymphoma | 2 (0.1%) | 0 (0%) | 0 (0%) | 0.230 | |
Fluid/Electrolyte Disorders | 81 (4.3%) | 1 (2.9%) | 274 (10.1%) | <0.001 | |
Other Neurological Disorders | 10 (0.5%) | 0 (0%) | 16 (0.6%) | 0.870 | |
Obesity | 67 (3.6%) | 1 (2.9%) | 25 (0.9%) | <0.001 | |
Psychoses | 27 (1.4%) | 2 (5.7%) | 11 (0.4%) | <0.001 | |
Pulmonary Circulation Disorders | 0 (0%) | 0 (0%) | 2 (0.1%) | 0.490 | |
Renal Failure | 2 (0.1%) | 0 (0%) | 2 (0.1%) | 0.920 | |
Solid Tumor | 1 (0.1%) | 0 (0%) | 2 (0.1%) | 0.950 | |
Valvular Disease | 3 (0.2%) | 0 (0%) | 12 (0.4%) | 0.240 | |
Weight Loss | 3 (0.2%) | 0 (0%) | 6 (0.2%) | 0.870 | |
Emergency Admission | 1565 (83.7%) | 24 (68.6%) | 2262 (83.9%) | 0.050 | |
Had a Procedure | 1533 (81.7%) | 9 (25.7%) | 255 (9.4%) | <0.001 | |
Mean (SD) | Mean (SD) | Mean (SD) | p | ||
Age, Years | 26.15 (6.14) | 27.23 (6.05) | 27.15 (5.94) | <0.001 | |
Time to First Procedure, Days | 0.85 (1.20) | 1.00 (0.76) | 1.39 (1.57) | <0.001 | |
Length of Stay, Days | 3.34 (2.37) | 2.29 (1.34) | 2.49 (1.52) | <0.001 | |
Total Charges, Dollars | 17,509 (15,506) | 11,695 (8743) | 10,554 (10,811) | <0.001 |
Elective, N (%) | Emergency, N (%) | p | ||
---|---|---|---|---|
All Cases | 748 (16.3%) | 3851 (83.7%) | ||
Age Group | 12–17 years | 39 (5.3%) | 173 (4.5%) | 0.220 |
18–21 years | 108 (14.4%) | 669 (17.4%) | ||
22–30 years | 381 (51.0%) | 1911 (49.7%) | ||
31+ years | 220 (29.3%) | 1089 (28.4%) | ||
Race | White | 394 (65.6%) | 1756 (53.2%) | <0.001 |
Black | 50 (8.3%) | 485 (14.7%) | ||
Hispanic | 98 (16.2%) | 754 (22.8%) | ||
Asian/Pacific Islander | 21 (3.5%) | 138 (4.2%) | ||
Native American | 5 (0.8%) | 25 (0.8%) | ||
Other | 34 (5.6%) | 146 (4.4%) | ||
Income Quartile | Quartile 1 | 221 (29.7%) | 1052 (27.6%) | 0.080 |
Quartile 2 | 190 (25.9%) | 872 (23.0%) | ||
Quartile 3 | 162 (21.7%) | 980 (25.8%) | ||
Quartile 4 | 169 (22.7%) | 895 (23.6%) | ||
Insurance | Private Insurance | 413 (55.5%) | 1887 (49.0%) | 0.003 |
Medicare | 3 (0.4%) | 23 (0.6%) | ||
Medicaid | 275 (36.7%) | 1652 (42.9%) | ||
Self-Pay | 21 (2.8%) | 165 (4.3%) | ||
No Charge | 3 (0.4%) | 16 (0.4%) | ||
Other | 31 (4.1%) | 107 (2.8%) | ||
Breast Diagnosis | Abscess of Breast | 304 (40.6%) | 1565 (40.6%) | 0.050 |
Infections of Nipple | 11 (1.5%) | 24 (0.6%) | ||
Nonpuerperal Mastitis | 433 (57.9%) | 2262 (58.7%) | ||
Severity | Minor Loss of Function | 365 (48.6%) | 1652 (43.0%) | 0.011 |
Moderate Loss of Function | 351 (46.7%) | 1959 (50.8%) | ||
Major Loss of Function | 35 (4.7%) | 222 (5.7%) | ||
Extreme Loss of Function | 0 (0%) | 19 (0.5%) | ||
Comorbidities | AIDS | 0 (0%) | 2 (0.1%) | 0.999 |
Alcohol Abuse | 1 (0.1%) | 3 (0.1%) | 0.510 | |
Deficiency Anemias | 37 (4.9%) | 284 (7.4%) | 0.017 | |
Rheumatoid Arthritis | 3 (0.4%) | 15 (0.4%) | 0.999 | |
Chronic Blood Loss | 37 (4.9%) | 266 (6.9%) | 0.048 | |
Congestive Heart Failure | 0 (0%) | 1 (0.0%) | 0.999 | |
Chronic Pulmonary Disease | 21 (2.8%) | 167 (4.3%) | 0.053 | |
Coagulopathy | 8 (1.1%) | 16 (0.4%) | 0.023 | |
Depression | 14 (1.9%) | 109 (2.8%) | 0.140 | |
Diabetes, Uncomplicated | 7 (0.9%) | 54 (1.4%) | 0.310 | |
Diabetes, Chronic Complications | 0 (0%) | 10 (0.3%) | 0.380 | |
Drug Abuse | 5 (0.7%) | 31 (0.8%) | 0.700 | |
Hypertension | 13 (1.7%) | 81 (2.1%) | 0.520 | |
Hypothyroidism | 13 (1.7%) | 77 (2.0%) | 0.640 | |
Liver Disease | 1 (0.1%) | 7 (0.2%) | 0.999 | |
Lymphoma | 1 (0.1%) | 0 (0.0%) | 0.160 | |
Fluid/Electrolyte Disorders | 37 (4.9%) | 318 (8.3%) | 0.002 | |
Other Neurological Disorders | 3 (0.4%) | 23 (0.6%) | 0.790 | |
Obesity | 12 (1.6%) | 81 (2.1%) | 0.380 | |
Psychoses | 6 (0.8%) | 34 (0.9%) | 0.830 | |
Pulmonary Circulation Disorders | 0 (0%) | 2 (0.1%) | 0.999 | |
Renal Failure | 0 (0%) | 4 (0.1%) | 0.999 | |
Solid Tumor | 1 (0.1%) | 2 (0.1%) | 0.410 | |
Valvular Disease | 3 (0.4%) | 12 (0.3%) | 0.720 | |
Weight Loss | 3 (0.4%) | 6 (0.2%) | 0.170 | |
Had a Procedure | 275 (36.8%) | 1516 (39.4%) | 0.180 | |
Mean (SD) | Mean (SD) | p | ||
Age, Years | 26.86 (6.01) | 26.72 (6.05) | 0.580 | |
Time to First Procedure, Days | 0.82 (1.15) | 0.94 (1.29) | 0.150 | |
Length of Stay, Days | 2.77 (1.84) | 2.84 (1.98) | 0.350 | |
Total Charges, Dollars | 10,677 (10,483) | 13,930 (13,801) | <0.001 |
Multivariable Linear Regression (HLOS) | |||
---|---|---|---|
N = 4387 | p | ||
β (95% CI) | |||
Intercept | 2.051 (1.981, 2.121) | <0.001 | |
Hospital Location | Urban: Teaching | 0.019 | |
Rural | 0.100 (–0.029, 0.230) | 0.130 | |
Urban: Non-Teaching | 0.112 (0.030, 0.193) | 0.007 | |
Breast Diagnosis | Abscess | 0.002 | |
Infection | –0.201 (–0.322, –0.079) | 0.001 | |
Mastitis | –0.387 (–0.817, 0.043) | 0.080 | |
Invasive Diagnostic Procedure | 0.364 (0.112, 0.617) | 0.005 | |
Surgical Procedure | 0.713 (0.602, 0.824) | <0.001 | |
Cesarean Section | 1.158 (0.203, 2.113) | 0.017 | |
Severity | Minor Loss of Function | <0.001 | |
Moderate Loss of Function | 0.292 (0.200, 0.384) | <0.001 | |
Major Loss of Function | 0.603 (0.426, 0.780) | <0.001 | |
Extreme Loss of Function | 0.766 (0.134, 1.398) | 0.018 | |
Comorbidities | Deficiency Anemias | 0.385 (0.231, 0.539) | <0.001 |
Drug Abuse | –0.784 (–1.254, –0.314) | 0.001 | |
Other Neurological Disorders | 0.522 (0.007, 1.037) | 0.047 | |
Obesity | 0.334 (0.052, 0.616) | 0.020 | |
Age, Years | Removed Via Backward Elimination | ||
Race | |||
Income Quartile | |||
Insurance | |||
Comorbidities | AIDS | ||
Alcohol Abuse | |||
Rheumatoid Arthritis | |||
Chronic Blood Loss | |||
Congestive Heart Failure | |||
Chronic Pulmonary Disease | |||
Coagulopathy | |||
Depression | |||
Diabetes, Uncomplicated | |||
Diabetes, Chronic Complications | |||
Hypertension | |||
Hypothyroidism | |||
Liver Disease | |||
Lymphoma | |||
Fluid/Electrolyte Disorders | |||
Psychoses | |||
Pulmonary Circulation Disorders | |||
Renal Failure | |||
Solid Tumor | |||
Valvular Disease | |||
Weight Loss |
No Procedure | Breast Procedure | Non-Breast Procedure | p | ||
---|---|---|---|---|---|
N (%) | |||||
Primary Diagnosis | Breast Abscess | 235 (12.5%) | 1541 (82.1%) | 100 (5.3%) | <0.001 |
Mastitis | 2157 (79.8%) | 279 (10.3%) | 267 (9.9%) | ||
Nipple Infection | 6 (31.6%) | 6 (31.6%) | 7 (36.8%) | ||
Race | White | 1232 (56.9%) | 743 (34.3%) | 192 (8.9%) | <0.001 |
Black | 187 (34.9%) | 310 (57.8%) | 39 (7.3%) | ||
Hispanic | 411 (47.8%) | 366 (42.6%) | 82 (9.5%) | ||
Asian/Pacific Islander | 80 (50%) | 65 (40.6%) | 15 (9.4%) | ||
Native American | 15 (50%) | 15 (50%) | 0 (0.0%) | ||
Other | 82 (45.3%) | 78 (43.1%) | 21 (11.6%) | ||
Income Quartile | Quartile 1 | 566 (44.2%) | 614 (47.9%) | 101 (7.9%) | <0.001 |
Quartile 2 | 569 (53.1%) | 414 (38.7%) | 88 (8.2%) | ||
Quartile 3 | 630 (54.7%) | 414 (36%) | 107 (9.3%) | ||
Quartile 4 | 619 (57.8%) | 356 (33.2%) | 96 (9%) | ||
Insurance | Private Insurance | 1364 (58.8%) | 764 (33%) | 190 (8.2%) | <0.001 |
Medicare | 14 (51.9%) | 13 (48.1%) | 0 (0%) | ||
Medicaid | 848 (43.8%) | 904 (46.7%) | 185 (9.6%) | ||
Self-Pay | 84 (44.4%) | 93 (49.2%) | 12 (6.3%) | ||
No Charge | 7 (36.8%) | 11 (57.9%) | 1 (5.3%) | ||
Other | 87 (62.6%) | 41 (29.5%) | 11 (7.9%) | ||
Mean (SD) | p | ||||
Age, Years | 27.15 (5.96) | 26.17 (6.17) | 26.96 (5.80) | <0.001 | |
Total Charges | 8902 (7072) | 18,856 (16,956) | 16,040 (14,213 | <0.001 | |
Length of Stay | 2.29 (1.13) | 3.52 (2.46) | 2.93 (1.89) | <0.001 | |
Days from Admission to First Procedure | 0.33 (0.5) | 0.97 (1.43) | 0.86 (1.48) | 0.196 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Koziol, K.J.; Smiley, A.; Latifi, R.; Castaldi, M.T. Predictive Risk Factors for Childbirth-Associated Breast Infections in the United States: A 10-Year Perspective. Int. J. Environ. Res. Public Health 2023, 20, 6333. https://doi.org/10.3390/ijerph20146333
Koziol KJ, Smiley A, Latifi R, Castaldi MT. Predictive Risk Factors for Childbirth-Associated Breast Infections in the United States: A 10-Year Perspective. International Journal of Environmental Research and Public Health. 2023; 20(14):6333. https://doi.org/10.3390/ijerph20146333
Chicago/Turabian StyleKoziol, Klaudia J., Abbas Smiley, Rifat Latifi, and Maria T. Castaldi. 2023. "Predictive Risk Factors for Childbirth-Associated Breast Infections in the United States: A 10-Year Perspective" International Journal of Environmental Research and Public Health 20, no. 14: 6333. https://doi.org/10.3390/ijerph20146333
APA StyleKoziol, K. J., Smiley, A., Latifi, R., & Castaldi, M. T. (2023). Predictive Risk Factors for Childbirth-Associated Breast Infections in the United States: A 10-Year Perspective. International Journal of Environmental Research and Public Health, 20(14), 6333. https://doi.org/10.3390/ijerph20146333